Rankings
▼
Calendar
WGS Q4 2024 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena
WGS
GeneDx Holdings Corp.
$3B
Q4 2024 Earnings
Healthcare
Medical - Healthcare Information Services
Income Statement
Revenue
$96M
+66.6% YoY
Gross Profit
$66M
69.2% margin
Operating Income
$9M
9.2% margin
Net Income
$5M
5.7% margin
EPS (Diluted)
$0.20
QoQ Revenue Growth
+24.4%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$6M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$419M
Total Liabilities
$174M
Stockholders' Equity
$245M
Cash & Equivalents
$85M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$96M
$57M
+66.6%
Gross Profit
$66M
$31M
+115.3%
Operating Income
$9M
-$26M
+134.3%
Net Income
$5M
-$26M
+121.1%
Revenue Segments
Diagnostic Test
$155M
50%
Diagnostic Test, Third Party Insurance
$123M
39%
Diagnostic Test, Institutional Customers
$31M
10%
Product and Service, Other
$3M
1%
Diagnostic Test, Self Pay
$1M
0%
← FY 2024
All Quarters
Q1 2025 →